n.红白血病

Erythroleukemia, also known as erythroleukocytosis, is a type of cancer that affects the blood and bone marrow.
红白血病，又称红细胞增多性白血病，是一种影响血液和骨髓的癌症。
The diagnosis of erythroleukemia typically involves a complete blood count (CBC) and a bone marrow biopsy.
红白血病的确诊通常包括全面血液计数（CBC）和骨髓活检。
Chemotherapy is the primary treatment for erythroleukemia, often in combination with radiation therapy.
化疗是治疗红白血病的主要方法，通常会与放射疗法结合使用。
In some cases, stem cell transplantation may be necessary to cure erythroleukemia in adults.
在某些情况下，成人可能需要进行干细胞移植来治愈红白血病。
Erythroleukemia can present with symptoms such as fatigue, easy bruising, and frequent infections.
红白血病的症状可能包括疲劳、易瘀伤和频繁感染。
The prognosis for erythroleukemia varies depending on the subtype, age of the patient, and stage of the disease.
红白血病的预后取决于其亚型、患者的年龄以及疾病的阶段。
Early detection and prompt treatment are crucial in managing erythroleukemia to improve survival rates.
早期发现和及时治疗对于管理红白血病以提高生存率至关重要。
Supportive care, including blood transfusions and medications to manage side effects, is often provided alongside treatment.
治疗期间通常会提供支持性护理，如输血和药物来管理副作用。
Researchers continue to explore new targeted therapies for erythroleukemia, hoping to find more effective and less toxic treatments.
研究人员仍在探索针对红白血病的新疗法，希望找到更有效且毒性较小的治疗方法。
Despite advancements in medicine, erythroleukemia remains a challenging condition to treat, highlighting the need for further research.
尽管医学取得了进步，红白血病仍然是一个难以治疗的疾病，这突显了进一步研究的必要性。